Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Biomonitoring data for 2,4-dichlorophenoxyacetic acid in the United States and Canada: interpretation in a public health risk assessment context using Biomonitoring Equivalents.

Aylward LL, Morgan MK, Arbuckle TE, Barr DB, Burns CJ, Alexander BH, Hays SM.

Environ Health Perspect. 2010 Feb;118(2):177-81. doi: 10.1289/ehp.0900970. Review.

2.

Biomonitoring Equivalents (BE) dossier for 2,4-dichlorophenoxyacetic acid (2,4-D) (CAS No. 94-75-7).

Aylward LL, Hays SM.

Regul Toxicol Pharmacol. 2008 Aug;51(3 Suppl):S37-48. doi: 10.1016/j.yrtph.2008.05.006. Epub 2008 May 22.

PMID:
18579270
3.

Interpreting biomonitoring data for 2,4-dichlorophenoxyacetic acid: Update to Biomonitoring Equivalents and population biomonitoring data.

Aylward LL, Hays SM.

Regul Toxicol Pharmacol. 2015 Dec;73(3):765-9. doi: 10.1016/j.yrtph.2015.11.001. Epub 2015 Nov 12.

PMID:
26577196
4.

Interpreting human biomonitoring data in a public health risk context using Biomonitoring Equivalents.

Hays SM, Aylward LL.

Int J Hyg Environ Health. 2012 Feb;215(2):145-8. doi: 10.1016/j.ijheh.2011.09.011. Epub 2011 Dec 20.

PMID:
22192580
5.

Biomonitoring Equivalents for bisphenol A (BPA).

Krishnan K, Gagné M, Nong A, Aylward LL, Hays SM.

Regul Toxicol Pharmacol. 2010 Oct;58(1):18-24. doi: 10.1016/j.yrtph.2010.06.005. Epub 2010 Jun 10. Review.

PMID:
20541576
6.

Using Biomonitoring Equivalents to interpret human biomonitoring data in a public health risk context.

Hays SM, Aylward LL.

J Appl Toxicol. 2009 May;29(4):275-88. doi: 10.1002/jat.1410. Review.

PMID:
19115313
7.

Public health interpretation of trihalomethane blood levels in the United States: NHANES 1999-2004.

LaKind JS, Naiman DQ, Hays SM, Aylward LL, Blount BC.

J Expo Sci Environ Epidemiol. 2010 May;20(3):255-62. doi: 10.1038/jes.2009.35. Epub 2009 Jun 24.

PMID:
19550438
8.

Derivation of Biomonitoring Equivalents for cyfluthrin.

Hays SM, Aylward LL, Gagné M, Krishnan K.

Regul Toxicol Pharmacol. 2009 Dec;55(3):268-75. doi: 10.1016/j.yrtph.2009.09.002. Epub 2009 Sep 12.

PMID:
19751788
9.

Biomonitoring equivalents for di-isononyl phthalate (DINP).

Hays SM, Aylward LL, Kirman CR, Krishnan K, Nong A.

Regul Toxicol Pharmacol. 2011 Jul;60(2):181-8. doi: 10.1016/j.yrtph.2011.03.013. Epub 2011 Apr 3.

PMID:
21466828
10.

Biomonitoring equivalents for deltamethrin.

Aylward LL, Krishnan K, Kirman CR, Nong A, Hays SM.

Regul Toxicol Pharmacol. 2011 Jul;60(2):189-99. doi: 10.1016/j.yrtph.2011.03.014. Epub 2011 Apr 3.

PMID:
21466827
11.

Derivation of Biomonitoring Equivalents for di(2-ethylhexyl)phthalate (CAS No. 117-81-7).

Aylward LL, Hays SM, Gagné M, Krishnan K.

Regul Toxicol Pharmacol. 2009 Dec;55(3):249-58. doi: 10.1016/j.yrtph.2009.09.001. Epub 2009 Sep 12.

PMID:
19751789
12.

Derivation of Biomonitoring Equivalents for di-n-butyl phthalate (DBP), benzylbutyl phthalate (BzBP), and diethyl phthalate (DEP).

Aylward LL, Hays SM, Gagné M, Krishnan K.

Regul Toxicol Pharmacol. 2009 Dec;55(3):259-67. doi: 10.1016/j.yrtph.2009.09.003. Epub 2009 Sep 12.

PMID:
19751787
13.

Biomonitoring Equivalents (BE) dossier for cadmium (Cd) (CAS No. 7440-43-9).

Hays SM, Nordberg M, Yager JW, Aylward LL.

Regul Toxicol Pharmacol. 2008 Aug;51(3 Suppl):S49-56. doi: 10.1016/j.yrtph.2008.05.008. Epub 2008 May 22.

PMID:
18579269
14.

Application of human biomonitoring (HBM) of chemical exposure in the characterisation of health risks under REACH.

Boogaard PJ, Aylward LL, Hays SM.

Int J Hyg Environ Health. 2012 Feb;215(2):238-41. doi: 10.1016/j.ijheh.2011.09.009. Epub 2011 Dec 15.

PMID:
22177527
15.

Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective.

Hays SM, Becker RA, Leung HW, Aylward LL, Pyatt DW.

Regul Toxicol Pharmacol. 2007 Feb;47(1):96-109. Epub 2006 Oct 6. Review.

PMID:
17030369
16.

Human biomonitoring as a pragmatic tool to support health risk management of chemicals--examples under the EU REACH programme.

Boogaard PJ, Hays SM, Aylward LL.

Regul Toxicol Pharmacol. 2011 Feb;59(1):125-32. doi: 10.1016/j.yrtph.2010.09.015. Epub 2010 Oct 7.

PMID:
20933039
17.

Biomonitoring Equivalents for triclosan.

Krishnan K, Gagné M, Nong A, Aylward LL, Hays SM.

Regul Toxicol Pharmacol. 2010 Oct;58(1):10-7. doi: 10.1016/j.yrtph.2010.06.004. Epub 2010 Jun 10. Review.

PMID:
20541577
18.

Biomonitoring Equivalents (BE) dossier for toluene (CAS No. 108-88-3).

Aylward LL, Barton HA, Hays SM.

Regul Toxicol Pharmacol. 2008 Aug;51(3 Suppl):S27-36. doi: 10.1016/j.yrtph.2008.05.009. Epub 2008 May 22.

PMID:
18583006
19.

Indirect sources of herbicide exposure for families on Ontario farms.

Arbuckle TE, Bruce D, Ritter L, Hall JC.

J Expo Sci Environ Epidemiol. 2006 Jan;16(1):98-104.

PMID:
16015277
20.

Deriving Biomonitoring Equivalents for selected E- and P-series glycol ethers for public health risk assessment.

Poet T, Ball N, Hays SM.

Int J Hyg Environ Health. 2016 Jan;219(1):88-100. doi: 10.1016/j.ijheh.2015.09.006. Epub 2015 Sep 30.

PMID:
26475513

Supplemental Content

Support Center